Search all trials

Find therapies in clinical trials near you – page 5

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Study of ODM-212 in Combination with Cancer Treatment for Patients with Advanced Solid Tumours

Recruiting

Registered drugNo placebo

Study of ODM-212 in Combination with Cancer Treatment for Patients with Advanced Solid Tumours

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Gemcitabine

Contact Research Centre

Non-small cell lung cancer stage III

Recruiting

Registered drugNo placebo

Pumitamig Versus Durvalumab in Patients With Unresectable Stage III Non-Small Cell Lung Cancer Without Progression After Chemoradiation

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Durvalumab

Contact Research Centre

Long-Term Safety and Efficacy of KL1333 in Adults with Primary Mitochondrial Disease

Recruiting

InvestigationalNo placebo

Long-Term Safety and Efficacy of KL1333 in Adults with Primary Mitochondrial Disease

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:2-Isopropyl-3H-Naphtho(1,2-D)Imidazole-4,5-Dione

Contact Research Centre

Chronic spontaneous urticaria

Recruiting

InvestigationalNo placebo

Remibrutinib in Chronic Spontaneous Urticaria for Patients Who Benefited from a Previous Remibrutinib Trial

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Remibrutinib

Contact Research Centre

Endocrine ophthalmopathy

Recruiting

InvestigationalNo placebo

AMG 732 in Patients With Thyroid Eye Disease Who Did Not Respond or Relapsed After Previous Treatment

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:AMG 732

Contact Research Centre

Hormone-dependent prostate cancer

Recruiting

Registered drugNo placebo

Docetaxel and Apalutamide in Patients with Metastatic Hormone-Sensitive Prostate Cancer Who Did Not Have a Deep PSA Response After Initial Apalutamide Treatment

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Apalutamide

Contact Research Centre

Bladder cancer

Recruiting

Registered drugNo placebo

Durvalumab and Chemotherapy in Adults With Muscle-Invasive Bladder Cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Durvalumab

Contact Research Centre

Neoplasm

Recruiting

InvestigationalNo placebo

Telisotuzumab Adizutecan for Locally Advanced or Metastatic Solid Tumors with MET Amplification in Patients 12 Years and Older

InvestigationalNo placebo

France

Participants:0–17 years · 18–64 years · 65+ years

Contact Research Centre

Chronic myeloid leukaemia

Recruiting

Registered drugNo placebo

Long-Term Safety Study of Asciminib in Patients With Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Registered drugNo placebo

France

Participants:0–17 years · 18–64 years · 65+ years
Substances:Bosutinib

Contact Research Centre

Multiple system atrophy

Recruiting

InvestigationalNo placebo

Open-Label Extension Study of ATH434-DP2 in Patients with Multiple System Atrophy

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:5,7-DICHLORO-2-((ETHYLAMINO)METHYL)-8-HYDROXY-3-METHYLQUINAZOLIN-4(3H)-ONE METHANESULFONATE

Contact Research Centre

Small cell lung cancer

Recruiting

Registered drugNo placebo

A Study of BI 764532, Atezolizumab, Carboplatin, and Etoposide in Patients With Extensive-Stage Small Cell Lung Cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Fallopian tube cancer+2

Recruiting

Registered drugNo placebo

Phase 3 Study of LY4170156 (Sofetabart Mipitecan) with drug combination in platinum‑resistant and platinum‑sensitive ovarian cancer patients

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Bevacizumab

Contact Research Centre

Find therapies in clinical trials near you – page 5

1 156 trials match your criteria

Study of ODM-212 in Combination with Cancer Treatment for Patients with Advanced Solid Tumours

Study of ODM-212 in Combination with Cancer Treatment for Patients with Advanced Solid Tumours

Non-small cell lung cancer stage III

Pumitamig Versus Durvalumab in Patients With Unresectable Stage III Non-Small Cell Lung Cancer Without Progression After Chemoradiation

Long-Term Safety and Efficacy of KL1333 in Adults with Primary Mitochondrial Disease

Long-Term Safety and Efficacy of KL1333 in Adults with Primary Mitochondrial Disease

Chronic spontaneous urticaria

Remibrutinib in Chronic Spontaneous Urticaria for Patients Who Benefited from a Previous Remibrutinib Trial

Endocrine ophthalmopathy

AMG 732 in Patients With Thyroid Eye Disease Who Did Not Respond or Relapsed After Previous Treatment

Hormone-dependent prostate cancer

Docetaxel and Apalutamide in Patients with Metastatic Hormone-Sensitive Prostate Cancer Who Did Not Have a Deep PSA Response After Initial Apalutamide Treatment

Bladder cancer

Durvalumab and Chemotherapy in Adults With Muscle-Invasive Bladder Cancer

Neoplasm

Telisotuzumab Adizutecan for Locally Advanced or Metastatic Solid Tumors with MET Amplification in Patients 12 Years and Older

Chronic myeloid leukaemia

Long-Term Safety Study of Asciminib in Patients With Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Multiple system atrophy

Open-Label Extension Study of ATH434-DP2 in Patients with Multiple System Atrophy

Small cell lung cancer

A Study of BI 764532, Atezolizumab, Carboplatin, and Etoposide in Patients With Extensive-Stage Small Cell Lung Cancer

Fallopian tube cancer+2

Phase 3 Study of LY4170156 (Sofetabart Mipitecan) with drug combination in platinum‑resistant and platinum‑sensitive ovarian cancer patients

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.